Life Sciences

UK Biobank Pioneers Global Advances in Medical Imaging
Technology UK Biobank Pioneers Global Advances in Medical Imaging

In the realm of medical technology and diagnostics, Faisal Zain stands out as a beacon of innovation and expertise. Specializing in the manufacturing and development of medical devices, Faisal has been instrumental in advancing medical research tools. In this interview, we explore the intricacies

AI Revolutionizes Oncology: Rakovina's Cutting-Edge Strategies
Care AI Revolutionizes Oncology: Rakovina's Cutting-Edge Strategies

In recent years, the integration of artificial intelligence in oncology has been nothing short of revolutionary, fundamentally altering the landscape of cancer treatment and diagnosis. AI has carved a path for enhanced precision in medicine, offering new methodologies that were previously

Can Cosentyx Transform GCA Treatment Amidst Challenges?
Care Can Cosentyx Transform GCA Treatment Amidst Challenges?

As the global population ages, diseases like Giant Cell Arteritis (GCA), which predominantly impact individuals over 50, are coming under increased scrutiny due to their debilitating effects. GCA, an autoimmune disorder that causes inflammation of blood vessels in the head and neck, can lead to

FDA Approves Lenacapavir: A Twice-Yearly HIV Prevention Breakthrough
Public Policy FDA Approves Lenacapavir: A Twice-Yearly HIV Prevention Breakthrough

Lenacapavir has recently been approved by the FDA as a twice-yearly injection, marking a significant milestone in the efforts toward global HIV prevention. This innovative treatment developed by Gilead Sciences, branded as Yetzugo, promises to revolutionize the landscape of HIV prevention efforts

Liposomal Drug Delivery – Review
Public Policy Liposomal Drug Delivery – Review

Liposomal drug delivery systems stand at the forefront of innovative approaches in pharmaceutical technology, particularly in addressing challenging and rare diseases like biliary tract cancer (BTC). BTC, known for its aggressive progression and limited treatment efficacy, affects approximately

AbbVie Buys Capstan to Advance In Vivo Cell Therapy
Technology AbbVie Buys Capstan to Advance In Vivo Cell Therapy

Imagine a world where reprogramming the cells inside our bodies can treat complex diseases traditionally managed through more invasive methods. AbbVie's acquisition of Capstan Therapeutics marks a significant step in turning this vision into reality. This monumental $2.1 billion deal promises

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later